The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2893|22|3|254-262

ISSN: 1352-0504

Source: JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.3, 2015-03, pp. : 254-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content